<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24898100</PMID>
<DateCompleted>
<Year>2015</Year>
<Month>01</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1573-2568</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>59</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2014</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Digestive diseases and sciences</Title>
<ISOAbbreviation>Dig. Dis. Sci.</ISOAbbreviation>
</Journal>
<ArticleTitle>Use of tenofovir disoproxil fumarate in highly viremic, hepatitis B mono-infected pregnant women.</ArticleTitle>
<Pagination>
<MedlinePgn>2797-803</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s10620-014-3230-3</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Antiviral therapy in addition to immunoprophylaxis at birth has been shown to further reduce perinatal transmission of hepatitis B virus (HBV) in highly viremic women.</AbstractText>
<AbstractText Label="AIMS" NlmCategory="OBJECTIVE">The aim of this study was to describe the use of tenofovir disoproxil fumarate (TDF) prophylaxis to reduce maternal HBV DNA levels and potentially vertical transmission in highly viremic women.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">After receiving IRB approval, we performed a retrospective chart review of mothers positive for hepatitis B surface antigen (HBsAg) who delivered between 2009 and 2012. We identified women with HBV DNA levels ≥6 log copies/mL who were treated with TDF in pregnancy.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">There were 22 women identified. The majority were of Micronesian ethnicity. All were negative for hepatitis C antibody and HIV infection. The median gestational age of TDF initiation was 31 weeks with a median duration of treatment of 45 days. There was a reduction in median HBV DNA levels from baseline 9.0 ± 2.0 to 5.4 ± 1.1 log copies/mL after treatment. There were five (22.7 %) preterm deliveries and five (22.7 %) cesarean deliveries. All infants received immunoprophylaxis at birth. Postnatal HBsAg testing at 9-12 months was available for 13 infants, 12 of which were negative. There was one case of perinatal transmission.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This is the second published case series to date on the use of TDF prophylaxis in HBV mono-infected, highly viremic mothers. This series suggests the use of TDF in pregnancy reduces maternal HBV DNA levels and is well tolerated.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tsai</LastName>
<ForeName>Pai-Jong Stacy</ForeName>
<Initials>PJ</Initials>
<AffiliationInfo>
<Affiliation>Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Women's Health, John A. Burns School of Medicine, University of Hawaii, 1319 Punahou Street, Suite 824, Honolulu, HI, 96826, USA, paijong@hawaii.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chang</LastName>
<ForeName>Ann</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yamada</LastName>
<ForeName>Seiji</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tsai</LastName>
<ForeName>Naoky</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bartholomew</LastName>
<ForeName>Marguerite Lisa</ForeName>
<Initials>ML</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P20 RR011091</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016430">Clinical Trial</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Dig Dis Sci</MedlineTA>
<NlmUniqueID>7902782</NlmUniqueID>
<ISSNLinking>0163-2116</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D063065">Organophosphonates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>99YXE507IL</RegistryNumber>
<NameOfSubstance UI="D000068698">Tenofovir</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>JAC85A2161</RegistryNumber>
<NameOfSubstance UI="D000225">Adenine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000225">Adenine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000031">analogs &amp; derivatives</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000998">Antiviral Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004279">DNA, Viral</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006509">Hepatitis B</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007231">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018445">Infectious Disease Transmission, Vertical</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016017">Odds Ratio</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D063065">Organophosphonates</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011247">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000068698">Tenofovir</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014766">Viremia</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2014</Year>
<Month>03</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2014</Year>
<Month>05</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2014</Year>
<Month>6</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2014</Year>
<Month>6</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2015</Year>
<Month>1</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">24898100</ArticleId>
<ArticleId IdType="doi">10.1007/s10620-014-3230-3</ArticleId>
<ArticleId IdType="pmc">PMC5894862</ArticleId>
<ArticleId IdType="mid">NIHMS956168</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Antivir Ther. 2011;16(8):1259-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22155907</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pediatr. 2008 Apr;152(4):582-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18346519</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Hepatol. 2013 Jul;59(1):24-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23485519</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Viral Hepat. 2003 Jul;10(4):294-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12823596</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Clin Pract. 2003 Mar;57(2):100-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12661791</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2012;7(7):e41011</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22848422</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2010 Sep 1;51(5):496-505</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20673002</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2002 May 30;346(22):1682-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12037146</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Obstet Gynecol. 2010 Jul;116(1):147-59</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20567182</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin HIV AIDS. 2013 Nov;8(6):528-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24100873</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Pharmacokinet. 2004;43(9):595-612</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15217303</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Dig Dis Sci. 2012 Sep;57(9):2423-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22543886</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>AIDS Patient Care STDS. 2009 Jul;23(7):513-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19530956</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatrics. 2003 May;111(5 Pt 2):1192-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12728137</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 1983 Nov 12;2(8359):1099-102</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6138642</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatrics. 2006 Sep;118(3):e711-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16923923</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2012 Dec 15;380(9859):2095-128</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23245604</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Hepatol. 2000 Jun;32(6):1040-1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10898328</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gastroenterol Hepatol. 2010 Jan;25(1):19-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20136972</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>World J Gastroenterol. 2011 Oct 14;17(38):4321-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22090789</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Viral Hepat. 2008 Jan;15(1):37-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18088243</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Opin Drug Saf. 2009 Nov;8(6):683-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19715450</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Med J Aust. 2009 May 4;190(9):489-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19413519</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Viral Hepat. 2012 Feb;19(2):e18-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22239517</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 1987 May 15;257(19):2612-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2952812</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):33-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23979002</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Med. 2012;9(5):e1001217</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22615543</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gastroenterology. 2011 Jan;140(1):132-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20955704</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>AIDS. 2012 Jun 1;26(9):1151-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22382151</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Gastroenterol Hepatol. 2012 May;10(5):520-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22343511</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2002 May;67(1):20-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11920813</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Viral Hepat. 2009 Feb;16(2):94-103</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19175878</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gut. 1996;38 Suppl 2:S37-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8786051</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Hepatol. 2011 Dec;55(6):1215-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21703206</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2008 Dec 4;359(23):2442-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19052126</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Pediatr Adolesc Med. 2011 Sep;165(9):837-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21536948</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>World J Gastroenterol. 2004 Mar 15;10(6):910-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15040044</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>